Citing 'excessive' executive compensation, advisory firms want a longtime Regeneron board member ousted
Grumbles have grown louder at Regeneron in recent months over the pay packages received by top execs, and now two large advisory firms are recommending shareholders oust a board member over the issue.
Glass Lewis and Institutional Shareholder Services both said that Regeneron board member George Sing, who sits on the company’s compensation committee, should be voted out ahead of an upcoming shareholder meeting this Friday. Sing has been a director at Regeneron since the company’s founding in 1988. According to Glass Lewis, whose report was provided to Endpoints News, concerns were expressed over the “excessive” stock awards given to CEO Leonard Schleifer and CSO George Yancopoulos.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 109,500+ biopharma pros reading Endpoints daily — and it's free.